$1.37
At close: Jun 26 EDT
$1.37
0.000.00%
Pre-Market: 7:48 AM EDT
Comments
Loading...
VYNE Therapeutics Stock Guidance | NASDAQ:VYNE | Benzinga
VYNE Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/26/2021 | VYNE | VYNE Therapeutics | Q4 | 2020 | — | — | — | $4.00M | $4.50M | $5.18M | Get Alert |
FAQ
What is the most recent guidance for VYNE Therapeutics (VYNE)?
There have been no specific sales or earnings guidance reported for VYNE Therapeutics in recent months.
Browse guidance and forecast on all stocks.
